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ABSTRACT We have developed an in vitro model of the
isolated chicken neural plate. Here we demonstrate that even
in the absence of notochord, the neural plate rapidly develops
a typical dorsoventral patterning. This observation suggests
that the ventral cell types are specified or at least predeter-
mined prior to notochord formation and that permissive
conditions are sufficient for differentiation of ventral struc-
tures. Treatment of the neural plate with activin A extin-
guishes Pax-6 gene expression, whereas the dorsal markers
Pax-3 and Pax-7 are still expressed. The absence of Pax-6
transcripts can be correlated with an impeded differentiation
of the motor neurons, whereas the floor plate seems to be
enlarged. We propose that the region-specific expression of
Pax-6 in the spinal cord is under the control of activin-like
molecules.
Several members of the vertebrate paired box (Pax) gene family
are expressed in restricted regions of the developing spinal cord
(1). While Pax-3 and Pax-7 transcripts are restricted to the dorsal
ventricular zone, Pax-6 transcripts are present in more-ventral
regions. The region-specific expression of these transcription
factors suggests that they might play an important role as regu-
lators of the dorsoventral patterning in that structure.
There is increasing evidence that cell differentiation in the
ventral part of the spinal cord is controlled by signals emanating
from the ventral midline cell groups: the notochord and the floor
plate (2). While grafting a second notochord lateral to the neural
plate induces the differentiation of an ectopic floor plate and of
ectopic columns of motor neurons, the absence of notochord
leads to the absence or delayed differentiation (3) of these ventral
cell types. Interestingly, a strong reorganization of the Pax gene
expression domains precedes the ectopic differentiation or the
absence of differentiation of ventral cell types (4, 5). In that
context, Pax-3 and Pax-6 are of particular interest because they
constitute very early markers responding to the ventralizing effect
of the ventral midline cells.
The aim of the present study is to identify the signaling
molecules involved in the regulation of the region-specific
expression of the Pax genes. For this purpose, we have estab-
lished an in vitro model. The caudal neural plate of a stage 10
chicken embryo was isolated by microsurgery and cultured
with or without the notochord in a collagen matrix. This in vitro
model presents two main advantages: (i) to show the potential
for differentiation of the caudal neural plate and (ii) to allow
the effect of various factors on Pax gene expression and on cell
differentiation to be tested. We have investigated the possible
influence of activin A on the region-specific expression of the
Pax genes in the spinal cord. Recent data suggest that this
molecule, first involved in cell specification in mesoderm
induction (6), might play an important role in neurogenesis (7).
Further, in tailbud-stage Xenopus embryo, inhibin/activin
mRNAwas detected, among other places, in the notochord (8).
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Since a high level of transcripts coding for the activin type IIA
receptor are present during the differentiation of chicken
neuroepithelium (9), we used activin A as a tool to determine
the influence of such molecules on Pax gene expression and on
cell differentiation.
MATERIALS AND METHODS
Microsurgery. A piece (300-400 ,um) of the open neural
plate positioned above Hensen's node (Fig. 1A) was excised
from stage 9-10 chicken embryos (10) after the surrounding
tissues were cleared off in 0.1% trypsin dissolved in Ca2+- and
Mg2+-free Tyrode's solution. The dorsal limit of the dissection
was at the junction between the neuroepithelium and the
surface ectoderm. When present, the notochord was kept at-
tached in its normal ventral position. In some cases the open
neural plate was divided into presumptive floor plate, ventral
plate, intermediate plate, and dorsal plate (11). The explanted
tissue was then washed in F-199 culture medium (Sigma)
supplemented with 5% fetal bovine serum, 2mM L-glutamine,
and 1% antibiotic solution (penicillin, 5000 units/ml; strepto-
mycin, 5000 ,ug/ml; GIBCO).
Explant Cultures. The explanted tissues were placed in a
tissue culture insert (diameter, 10 mm; Nunc) containing 40 ,ul
of rat tail collagen mixture (3 mg/ml; rat tail collagen was from
Boehringer Mannheim). Explants were cultured in the me-
dium described above at 37°C in a 5% CO2 atmosphere. At
least two groups of five cultures were analyzed in each case
except when mentioned in Results.
Activin A Treatment. A recombinant human activin A (12)
was diluted to the desired final concentration in culture
medium containing 5% fetal bovine serum. The medium was
replaced every 24 hr. To control for the specificity of the
activin treatment, culture medium containing activin A at 150
ng/ml was incubated for 2 hr at 37°C with follistatin fixed on
Affi-Gel beads (Bio-Rad) (a gift from Y. Eto, Central Re-
search Laboratories, Ajinomoto, Japan), centrifuged for 10
min at 8500 x g and then used as culture medium. Activin
effects were completely abolished in such conditions. The
percent inhibition ofPax-6 expression with increasing concen-
trations of activin was quantified with the NIH IMAGE 1.56
program (kindly provided by W. Rasband, National Institutes
of Health). The domain expressing Pax-6 was measured with
this program in five independent explants.
Whole-Mount in Situ Hybridization. Pax-3, Pax-6, andPax-7
transcripts were analyzed with antisense RNA probes corre-
sponding respectively to nt 468-1113 (13), 345-908 (14), and
86-720 (15) of the equivalent mouse cDNA. Prior to fixation,
the cultures were incubated for 1-2 min with collagenase type
V (Sigma) dissolved at 1 mg/ml in 50 mM tricine, pH 7.5/0.4
M NaCl/10mM CaCl2. The whole-mount in situ procedure was
performed according to Wilkinson (16).
Whole-Mount Antibody Staining. After collagenase treat-
ment as described above, immunostaining was monitored
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FIG. 1. Pax-3 and Pax-6 transcripts detected by whole-mount in situ
hybridization in 1-day-old neural plate culture. Schematic represen-
tation (A) shows the level of explantation of the open neural plate on
a stage 10 chicken embryo. Pax-3 (B-E) and Pax-6 (G-J) expression
domains were observed in the presence (B, C, F, and G) or absence (D,
E, and H-J) of notochord. Double in situ detection (F) shows the
respective expression domain of Pax-3 (in red) and Pax-6 (in blue) in
the presence of notochord. B, D, F, and H represent lateral views and
I represents a ventral view of the whole explants. C, E, G, and J
correspond to representative cross-sections through such cultures. In
each photograph the dorsal side of the explant is at the top, except
where indicated otherwise. n, Notochord; D, dorsal; V, ventral. [Bar
= 100 ,um (B, D, H, and I), 90 ,um (F), or 50 ,um (C, E, G, and J).]
according to Wright et al. (17). The absence of notochordal cell
contaminations on the neural plate cultured alone was verified
with the monoclonal antibody Notl obtained from the Devel-
opmental Studies Hybridoma Bank (data not shown). The
polyclonal antibody to Isl-1 (working dilution, 1:100) was a gift
from S. Thor (18). The monoclonal antibody JC7/SC1 (here-
after JC7; working dilution, 1:500) was a gift from J. Covault
(19). The appropriate secondary antibodies were purchased
from Organon Teknika-Cappel.
Vibratome Sectioning. The samples were embedded in a
gelatin/albumin mixture and sectioned at 30 ,um with a
vibrating microtome.
RESULTS
Expression ofPax Genes in the Caudal Neural Plate Grown
24 hr in Culture. To determine whether the neural tube would
respond to regulatory signals in the same way in vitro as in vivo,
small pieces of the open neural plate of stage 10 embryos were
explanted and cultured in a collagen matrix with or without the
underlying notochord (Fig. 1A). After 24 hr in vitro these
cultures were analyzed by whole-mount in situ hybridization
with antisense RNA probes recognizing Pax-3, Pax-6, or Pax-7
transcripts.
In the presence of notochord, Pax-3 expression was re-
stricted to the most dorsal part of the neural tube (Fig. 1 B and
C), whereas Pax-6 was expressed in the dorsolateral part of this
tissue (Fig. 1 F and G) partially overlapping with the Pax-3-
expressing region but extending more ventrally. As expected,
no staining was observed in the most ventral part of the neural
tube. In the absence of notochord, the ventral limit of Pax-3
expression extended more ventrally but still excluded the
midline cells (Fig. 1 D and E). Surprisingly, Pax-6, which is
either absent or expressed at a very low level in the most
ventral part of the neural tube after deletion of the notochord
in vivo, was still strongly expressed in these cultures as two
bands on both side of the ventral midline (Fig. 1 H-J).
Nevertheless, like Pax-3, the expression domain of Pax-6 also
showed a clear ventral shift (Fig. 1H). The pattern of Pax-7
expression was comparable to the one observed for Pax-3 (data
not shown).
In the absence of notochord, the strong Pax-6 expression can
be dependent on the presence of the cells at the ventral
midline. To test this hypothesis, the open neural plate was
separated into ventral, intermediate, and dorsal plate and each
piece was cultured separately. Despite the absence of ventral
midline cells, Pax-6 expression was detected in ventral plates
(see Fig. 4B) but not in lateral or dorsal plates (data not
shown).
Differentiation of Ventral Cell Types in the Open Neural
Plate Grown in Vitro. The possible differentiation of ventral
cell types in our culture model was analyzed by double
immunostaining. We used a polyclonal antibody against Isl-1
(islet 1), which is the earliest marker for motor neurons (18),
and the monoclonal antibody JC7, which recognizes a cell
surface adhesion molecule present both on the motor neurons
and on the floor plate (19). Apart from these ventral cell types,
both antibodies label cells located in the dorsal root ganglion
and in the dorsal part of the neural tube.
When the open neural plate was cultured for 3 days in the
presence of notochord, two symmetric groups of Isl-1-positive
nuclei were clearly visible in the lateral plates of the neural
tube (Fig. 2A4). Some of these cells were also JC7-immuno-
positive. In these cultures, an average of 39 + 8 Isl-1-positive
nuclei per section (n = 8 cultures, 5 sections counted per
culture) were found positioned in these two columns of
putative motor neurons. A strong JC7 immunostaining was
also observed in a triangular structure at the level of the ventral
midline. These JC7-positive but Isl-1-negative cells constituted
the floor plate (Fig. 24).
In the absence of notochord, again two symmetric groups of
Isl-1/JC7-positive cells were observed in 3-day-old cultures
(Fig. 2B). The Isl-1-positive nuclei, localized more ventrally
than in the presence of notochord, were also less numerous (15
± 4 positive nuclei per section, n = 7 cultures, 5 sections per
culture). The presence at the ventral midline of cells that were
JC7-immunopositive but Isl-1-negative suggested that a floor
plate-like structure developed in the neural tube even in the
absence of notochord (Fig. 2B).
Activin A Abolishes Pax-6 Expression in a Dose-Dependent
Manner. To determine whether activin A could regulate Pax
gene expression in the neural plate, various concentrations of
this factor, 5-600 ng/ml, were added to the culture medium.
In choosing this range of concentrations, we took into account
that 5 ng/ml (0.2 nM) corresponds to 1 unit (12) and that an
activin A concentration of 200 ng/ml is necessary to increase
goosecoid mRNA accumulation in mouse embryos (20). The







6954 Developmental Biology: Pituello et al.
A B I
FIG. 2. Cell differentiation in neural plate cultures. (A and B) Vibratome sections showing the characteristic double immunostaining observed
in 3-day-old cultures in the presence (A) or absence (B) of notochord. Isl-1 immunoreactivity is shown in brown and JC7 immunoreactivity in blue.
Note the presence of a few positive cells in the dorsal part of the neural tube (arrowhead). (C) Effect of activin A on cell differentiation. The motor
neuron columns are no longer visible, but some scarce positive cells are present in the neural tube. A very strong and expanded JC7 staining is
observed at the ventral midline. n, Notochord. (Bar = 50 ,um.)
neural plates explanted without notochord were cultured in the
presence of activin A for 24 hr, fixed, and analyzed for Pax-6
expression.
For doses lower than 50 ng/ml, no significant effect on Pax-6
expression was observed. At 50 ng/ml, Pax-6 expression was
clearly reduced, with only 50% of the staining left (Fig. 3B).
The characteristic expression pattern of Pax-6 (i.e., two bands
of positive cells in both side of the ventral midline) was still
discernible, suggesting that the progressive disappearance of
the transcripts was not accompanied by a ventral shift (Fig.
3B). At 100 ng/ml, the effect was more pronounced, with an
-75% decrease in the staining (Fig. 3C); above 150 ng/ml,
Pax-6 expression was completely abolished (Fig. 3D).
To define whether the effect of activinA on Pax-6 expression
was mediated by the cells at the ventral midline, the ventral
plate was separated from the ventral midline and from the
intermediate plate and cultured in the presence of activin A.
Pax-6 expression was abolished in ventral plate cultured in the
presence of activin (Fig. 4), showing that the effect can be
independent of the presence of the ventral midline cells.
Expression of the Dorsal Markers Pax-3 and Pax-7 Is Not
Abolished by Activin A. To determine whether activinA would
similarly influence the expression of the dorsal Pax genes, the
neural plates were cultured for 24 hr in presence of activin A
(150 ng/ml) and the expression of Pax-3 and Pax-7 was ana-
lyzed. Both Pax-3 and Pax-7 were expressed in the activin-
treated cultures (Fig. 5).
Effect of Activin A Treatment on Cell Differentiation. To
determine whether activin would affect cell differentiation in
vitro, double immunostaining experiments were performed as
described above on 3-day-old cultures treated with activin A
(150 ng/ml). While the presence at the ventral midline of
JC7-positive but Isl-1-negative cells suggested that a floor
plate-like structure still differentiated in the presence of
activin A, the two clusters of Isl-1/JC7-positive cells, clearly
visible on both sides of the floor plate in the control cultures,
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FIG. 3. Pax-6 expression in neural plates (ventral view) cultured for
24 hrwithout activinA (A) orwith activinA at 50 ng/ml (B), 100 ng/ml
(C), or 150 ng/ml (D). (Bar = 100 gLm.)
(Fig. 2C). Some scarce positive cells were present in the dorsal
part of the neural tube.
DISCUSSION
Permissive Conditions Are Sufficient for the Caudal Neural
Plate to Differentiate Ventral Cell Types. In the chicken
embryo, deletion of the notochord under the caudal neural
plate leads to a strong reorganization of the Pax expression
domains, followed by the absence or the delayed differentia-
tion of ventral structures (4). However, our data demonstrate
that the caudal neural plate isolated in culture displays rapidly
a typical dorsoventral patterning according to Pax gene ex-
pression domains. Later, the differentiation of a floor plate
and of motor neurons proceeds in such cultures. Other authors
have reported the differentiation of ventral cell types in the
spinal cord differentiating in vitro or in vivo without notochord
(3, 11). Therefore, despite the fact that the notochord has a
strong floor plate-inducing ability (21), these data suggest that
the initial inductive interaction takes place before notochord
organization. This suggestion supports the model proposed by
Artinger and Bronner-Fraser (3), in which either the floor
plate is induced early by the chordamesoderm of Hensen's
node or limited interactions between predisposed ventral
neural midline cells and the notochord immediately after
neurulation are sufficient for floor plate determination. An
alternative is that the prospective ventral neuroepithelial cells
are predetermined to differentiate a floor plate according to
their lineage. The observation that prospective median (ven-
tral) and prospective lateral neuroepithelial cells exhibit be-
havior differences prior to notochord inductive interaction
supports such a hypothesis (22).
Nevertheless, permissive conditions are necessary to get the
expression of these ventral traits. Indeed, in the chicken em-
bryo 2 days after notochord ablation, the neural tube presents
a dorsalized fate as indicated by the pattern of Pax gene
A
FIG. 4. Activin abolishes Pax-6 expression even in the absence of
midline cells. (A) Schematic representation showing the limits of
dissection for the presumptive floor plate (f), ventral plate (v),
intermediate plate (i), and dorsal plate (d). (B and C) One-day-old
ventral plates (v) cultured in the absence (B) or presence (C) of activin.
(Bar = 100 gm.)
Proc. Natl. Acad. Sci. USA 92 (1995)





FIG. 5. Pax-3 and Pax-7 expression in neural plate explants treated with activin A. Whole mount in situ staining shows Pax-3 (A-D) or Pax-7(E-H) expression in 1-day-old control cultures (A, B, E, and F) or in 1-day-old activin-treated (150 ng/ml) cultures (C, D, G, and H). A, C, E, and
G are ventral views of whole neural tubes, and B, D, F, andH are the corresponding cross-sections. In B, D, F, andH the dorsal side of the section
is at the top, and the ventral side is at the bottom. [Bar = 100 ,um (A, C, E, and G) or 50 ,um (B, D, F, and H).]
expression as well as by the absence of ventral cell-type
differentiation (4, 23). Since the neural plate never undergoes
a complete dorsalization in vitro, this may reflect either the
presence of permissive ventralizing factor(s) in these cultures
(perhaps due to the presence of5% fetal bovine serum) or the
absence of inhibitors of the ventral differentiation. In vivo,
such an inhibitory effect could be due to the surface ectoderm
and/or the paraxial mesoderm, both of which are in close
contact with the developing neural tube.
Activin-Like Molecules and Dorsoventral Polarity of the
Neural Tube. Pax-6 expression in the spinal cord is initially
detected in a broad band of cells, with the exception of prospec-
tive roof plate and floor plate cells, and then is progressively
repressed in both the dorsal and the ventral region, resulting in
the region-specific expression ofPax-6 in the mid-lateral region of
the spinal cord (4). Are activins expressed at the right time and
place to regulate Pax-6 expression in the spinal cord? After neural
tube closure, inhibin/activin f3B mRNA is detected in cells
located in the dorsal part of the neural tube and in the notochord
(27). Therefore, activins may be involved in both the dorsal and
ventral downregulation events which lead to Pax-6 expression in
the mid-lateral region of the spinal cord (see model in Fig. 6). The
grafting of a supernumerary notochord beneath the closing
neural plate rapidly represses Pax-6 expression in cells adjacent to
the graft (4), an observation compatible with the hypothesis that
activins may play an important role in the regulation of Pax-6
expression in the ventral part of the spinal cord.
Besides inhibiting Pax-6 expression, activin also affects cell
differentiation in our in vitro model (Fig. 6). In the ventral part
of the neural tube, the two motor neuron columns are either
absent or underdeveloped after treatment with activin. Three
main scenarios can be proposed to explain the absence of
motor neuron differentiation. (i) Activin A may mimic the
effect of dorsalizing factors such as Dsl-1 (24). Dsl-1, which is
present in the dorsal region of the spinal cord, has been shown
to inhibit the differentiation of the motor neurons in vitro.
However, activin A seems to stimulate floor plate differenti-
ation, an observation which is difficult to explain as a dorsalin-
like effect. (ii) The absence of motor neuron differentiation
observed in activin-treated explants may be directly related to
the prior extinction of Pax-6 expression. (iii) High concentra-
tions of activin A may favor the differentiation of other neural
cell types at the expense of motor neuron differentiation (Fig.
6). Activins have been shown to act as morphogens in meso-
derm induction (6) and could play a similar role in spinal cord
development. Several studies indicate that distinct classes of
neural cells in the ventral neural tube are induced by the
ventral midline cell groups, the floor plate, and notochord (23,
25). Cells in the proximity of a source of activin would be
i) Activins control Pax-6 expression domain
A) Directly by diffusion B) indirectly by induction of
secondary signalling molecules
ii) Activins influence the differentiation of ventral cell types
C) Directly by diffusion D) indirectly by favoring
floor plate differentiation
FIG. 6. Diagrams summarizing the possible functions of activin-
like molecules in the regulation of Pax-6 expression and cell differ-
entiation. (i) Establishment of the region-specific expression of Pax-6.
The two putative sources of activins are cells in the dorsal part of the
neural tube and the notochord. (A) Activins may diffuse from these
sources and repress Pax-6 expression, leading to its specific expression
domain (in white on the diagram). (B) Despite the fact that activin A
can abolish Pax-6 expression in vitro in the absence of ventral midline
cells (see Results), we cannot exclude the possibility that, in the ventral
and/or dorsal zone of the neural tube, activins induce secondary
signaling molecules involved in Pax-6 regulation. (ii) Activins may
influence ventral cell differentiation. With (C) or without (D) activin
diffusion throughout the neural tube, the cells exposed to the highest
concentrations of activins in the ventral part of the neural tube are
those positioned in the proximity of the notochord, such as the floor
plate precursors. High concentrations of activins may favor their
differentiation, whereas low concentrations or no activin may be a
permissive condition for cells positioned further away from the
notochord, such as the motor neurons.
Developmental Biology: Pituello et al.
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submitted to the highest concentrations of that factor. High
concentrations of activins would thus favor the differentiation
of these cells whereas low concentrations of activin or the
absence of activin could be the permissive condition for
differentiation of cells which are farther away from the activin
source. An interesting observation in agreement with this
hypothesis is that high concentrations of activin A seem to
favor the differentiation of the floor plate whereas differen-
tiation of motor neurons may be repressed.
In conclusion, we propose that activin-like molecules may
play an important role as regulators of the region-specific
expression of Pax-6 and therefore in the control of the
dorsoventral polarity in the developing spinal cord. Further, it
has recently been suggested that the formation of the nervous
system might be the result of the derepression of a default state
(26). The data presented here lead us to suggest that the
differentiation of ventral cell types could proceed by following
the same scenario. The initial inductive event leading to the
ventralization of the spinal cord seems to take place prior to
notochord formation. Therefore, ventral cell types are already
specified in the open neural plate and permissive conditions
would be sufficient for their differentiation. In the absence of
notochord, the ectopic presence of inhibitor(s) could repress
the differentiation of these precursor cells. The presence of the
notochord would create permissive conditions for their differ-
entiation. Their differentiation would then be the result of the
derepression of a default state.
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